myNEO
myNEO is developing personalized cancer vaccines designed using genomic tumor fingerprints, which teach the body's defences to recognize tumor neoantigens, eliminate related cancer cells, and prevent metastasis.
myNEO is developing personalized cancer vaccines designed using genomic tumor fingerprints, which teach the body's defences to recognize tumor neoantigens, eliminate related cancer cells, and prevent metastasis.